Cargando…
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease
COVID-19 convalescent plasma (CP) may be a safe and effective treatment option in SARS-CoV-2 infection refractory to remdesivir. Infants may benefit from CP despite developing immune systems and donor variability emphasizes the need for characterization prior to use.
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509858/ https://www.ncbi.nlm.nih.gov/pubmed/32915971 http://dx.doi.org/10.1182/bloodadvances.2020002507 |
| _version_ | 1783585680783310848 |
|---|---|
| author | Rodriguez, Zahidee Shane, Andi L. Verkerke, Hans Lough, Christopher Zimmerman, Matthew G. Suthar, Mehul Wrammert, Jens MacDonald, Heather Wolf, Michael Clarke, Shanelle Roback, John D. Arthur, Connie M. Stowell, Sean R. Josephson, Cassandra D. |
| author_facet | Rodriguez, Zahidee Shane, Andi L. Verkerke, Hans Lough, Christopher Zimmerman, Matthew G. Suthar, Mehul Wrammert, Jens MacDonald, Heather Wolf, Michael Clarke, Shanelle Roback, John D. Arthur, Connie M. Stowell, Sean R. Josephson, Cassandra D. |
| author_sort | Rodriguez, Zahidee |
| collection | PubMed |
| description | COVID-19 convalescent plasma (CP) may be a safe and effective treatment option in SARS-CoV-2 infection refractory to remdesivir. Infants may benefit from CP despite developing immune systems and donor variability emphasizes the need for characterization prior to use. |
| format | Online Article Text |
| id | pubmed-7509858 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75098582020-09-23 COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease Rodriguez, Zahidee Shane, Andi L. Verkerke, Hans Lough, Christopher Zimmerman, Matthew G. Suthar, Mehul Wrammert, Jens MacDonald, Heather Wolf, Michael Clarke, Shanelle Roback, John D. Arthur, Connie M. Stowell, Sean R. Josephson, Cassandra D. Blood Adv Exceptional Case Report COVID-19 convalescent plasma (CP) may be a safe and effective treatment option in SARS-CoV-2 infection refractory to remdesivir. Infants may benefit from CP despite developing immune systems and donor variability emphasizes the need for characterization prior to use. American Society of Hematology 2020-09-11 /pmc/articles/PMC7509858/ /pubmed/32915971 http://dx.doi.org/10.1182/bloodadvances.2020002507 Text en © 2020 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Exceptional Case Report Rodriguez, Zahidee Shane, Andi L. Verkerke, Hans Lough, Christopher Zimmerman, Matthew G. Suthar, Mehul Wrammert, Jens MacDonald, Heather Wolf, Michael Clarke, Shanelle Roback, John D. Arthur, Connie M. Stowell, Sean R. Josephson, Cassandra D. COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease |
| title | COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease |
| title_full | COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease |
| title_fullStr | COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease |
| title_full_unstemmed | COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease |
| title_short | COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease |
| title_sort | covid-19 convalescent plasma clears sars-cov-2 refractory to remdesivir in an infant with congenital heart disease |
| topic | Exceptional Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509858/ https://www.ncbi.nlm.nih.gov/pubmed/32915971 http://dx.doi.org/10.1182/bloodadvances.2020002507 |
| work_keys_str_mv | AT rodriguezzahidee covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT shaneandil covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT verkerkehans covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT loughchristopher covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT zimmermanmatthewg covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT sutharmehul covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT wrammertjens covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT macdonaldheather covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT wolfmichael covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT clarkeshanelle covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT robackjohnd covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT arthurconniem covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT stowellseanr covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease AT josephsoncassandrad covid19convalescentplasmaclearssarscov2refractorytoremdesivirinaninfantwithcongenitalheartdisease |